Determination of Lung Maturity and Prediction of RDS at Birth
Spectroscopic-chemometric Determination of Lecithin-sphingomyelin Ratio in Gastric Aspirates and Secretion From Hypopharynx at Birth, in Relation to Development of RDS
1 other identifier
observational
145
1 country
1
Brief Summary
The overall objective is to identify quickly after birth the preterm infants who will develop respiratory distress syndrome (RDS) for the purpose of treating them as early as possible with surfactant, to reduce, and if possible, to avoid sequelae, including long-term oxygen treatment. We have therefore developed a quick test, which we believe will be ideal for this type of diagnostics, and will now test the method in a preclinical trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2014
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 28, 2014
CompletedStudy Start
First participant enrolled
March 1, 2014
CompletedFirst Posted
Study publicly available on registry
March 3, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2015
CompletedJanuary 30, 2015
January 1, 2015
10 months
February 28, 2014
January 29, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
RDS
5 days
Study Arms (2)
Gastric aspirate
L/S ratio on the gastric aspirates are retrospectively compared with the possible development of RDS
Hypopharyngeal secretion
L/S ratio on the hypopharyngeal secretions are retrospectively compared with the possible development of RDS
Eligibility Criteria
135 preterm infants with gestational age 24-32 weeks (24+0 to 31+6)
You may qualify if:
- Preterm infants with gestational ages of 24 (24+0) to 32 (31+6) weeks.
- Age \< ½ hour
You may not qualify if:
- Lack of informed consent
- lack of aspirate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Henrik Axel Verderlead
- Holbaek Sygehuscollaborator
- Aalborg University Hospitalcollaborator
- Odense University Hospitalcollaborator
- Aarhus University Hospital Skejbycollaborator
- Kolding Sygehuscollaborator
- Copenhagen University Hospital at Herlevcollaborator
- Rigshospitalet, Denmarkcollaborator
- Hvidovre University Hospitalcollaborator
- Naestved Hospitalcollaborator
- University Hospital, Linkoepingcollaborator
- Skane University Hospitalcollaborator
Study Sites (1)
Holbaek Sygehus
Holbæk, 4300, Denmark
Biospecimen
Gastric- and hypopharyngeal secretions
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Henrik Verder, Professor MD
Holbaek Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor DMSc
Study Record Dates
First Submitted
February 28, 2014
First Posted
March 3, 2014
Study Start
March 1, 2014
Primary Completion
January 1, 2015
Study Completion
January 1, 2015
Last Updated
January 30, 2015
Record last verified: 2015-01